Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.290
+0.170 (15.18%)
At close: Dec 20, 2024, 4:00 PM
1.280
-0.010 (-0.78%)
After-hours: Dec 20, 2024, 7:59 PM EST
Actinium Pharmaceuticals Market Cap
Actinium Pharmaceuticals has a market cap or net worth of $40.24 million as of December 20, 2024. Its market cap has decreased by -72.30% in one year.
Market Cap
40.24M
Enterprise Value
-36.71M
1-Year Change
-72.30%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since December 27, 2012, Actinium Pharmaceuticals's market cap has increased from $16.70M to $40.24M, an increase of 140.97%. That is a compound annual growth rate of 7.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 40.20M | -71.14% |
| Dec 29, 2023 | 139.30M | -48.67% |
| Dec 30, 2022 | 271.40M | 104.98% |
| Dec 31, 2021 | 132.40M | 24.91% |
| Dec 31, 2020 | 106.00M | 195.26% |
| Dec 31, 2019 | 35.90M | -19.87% |
| Dec 31, 2018 | 44.80M | -15.63% |
| Dec 29, 2017 | 53.10M | 8.81% |
| Dec 30, 2016 | 48.80M | -64.04% |
| Dec 31, 2015 | 135.70M | -23.20% |
| Dec 31, 2014 | 176.70M | 26.85% |
| Dec 31, 2013 | 139.30M | 734.13% |
| Dec 31, 2012 | 16.70M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAB Biotherapeutics | 35.99M |
| FibroGen | 35.64M |
| Precision BioSciences | 35.29M |
| Movano | 35.27M |
| VYNE Therapeutics | 35.26M |
| NEXGEL | 34.73M |
| Lantern Pharma | 34.62M |
| Marker Therapeutics | 33.28M |